Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancer.
Burdelski C, Borcherding L, Kluth M, Hube-Magg C, Melling N, Simon R, Möller-Koop C, Weigand P, Minner S, Haese A, Michl HU, Tsourlakis MC, Jacobsen F, Hinsch A, Wittmer C, Lebok P, Steurer S, Izbicki JR, Sauter G, Krech T, Büscheck F, Clauditz T, Schlomm T, Wilczak W.
Burdelski C, et al. Among authors: weigand p.
Oncotarget. 2017 May 9;8(19):31494-31508. doi: 10.18632/oncotarget.16357.
Oncotarget. 2017.
PMID: 28415558
Free PMC article.